BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21799839)

  • 1. Levels of spending and resource allocation to HIV programs and services in Latin America and the Caribbean.
    Arán-Matero D; Amico P; Arán-Fernandez C; Gobet B; Izazola-Licea JA; Avila-Figueroa C
    PLoS One; 2011; 6(7):e22373. PubMed ID: 21799839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.
    Haakenstad A; Moses MW; Tao T; Tsakalos G; Zlavog B; Kates J; Wexler A; Murray CJL; Dieleman JL
    Lancet HIV; 2019 Jun; 6(6):e382-e395. PubMed ID: 31036482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of government HIV/AIDS financing: a 10-year trend analysis from 125 low- and middle-income countries.
    Ávila C; Loncar D; Amico P; De Lay P
    BMC Public Health; 2013 Jul; 13():673. PubMed ID: 23870494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financing the response to HIV in low-income and middle-income countries.
    Izazola-Licea JA; Wiegelmann J; Arán C; Guthrie T; De Lay P; Avila-Figueroa C
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S119-26. PubMed ID: 19901624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV among gay and other men who have sex with men in Latin America and the Caribbean: a hidden epidemic?
    Cáceres CF
    AIDS; 2002 Dec; 16 Suppl 3():S23-33. PubMed ID: 12685922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries.
    Amico P; Gobet B; Avila-Figueroa C; Aran C; De Lay P
    BMC Public Health; 2012 Mar; 12():221. PubMed ID: 22436141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource requirements to fight HIV/AIDS in Latin America and the Caribbean.
    Opuni M; Bertozzi S; Bollinger L; Gutierrez JP; Massiah E; McGreevey W; Stover J
    AIDS; 2002 Dec; 16 Suppl 3():S58-65. PubMed ID: 12685926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of HIV in Latin America and the Caribbean.
    García PJ; Bayer A; Cárcamo CP
    Curr HIV/AIDS Rep; 2014 Jun; 11(2):146-57. PubMed ID: 24824881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.
    Resch S; Ryckman T; Hecht R
    Lancet Glob Health; 2015 Jan; 3(1):e52-61. PubMed ID: 25539970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region.
    Calleja JM; Walker N; Cuchi P; Lazzari S; Ghys PD; Zacarias F
    AIDS; 2002 Dec; 16 Suppl 3():S3-12. PubMed ID: 12685919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and AIDS research in Latin America and the Caribbean: 1983-1991.
    Epidemiol Bull; 1993 Mar; 14(1):10-2. PubMed ID: 8485030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.
    Costa JM; Torres TS; Coelho LE; Luz PM
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29356390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
    Avdeeva O; Lazarus JV; Aziz MA; Atun R
    J Int AIDS Soc; 2011 Oct; 14():51. PubMed ID: 22029667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and HTLV-I infections in the Americas: a regional perspective.
    Quinn TC; Zacarias FR; St John RK
    Medicine (Baltimore); 1989 Jul; 68(4):189-209. PubMed ID: 2544782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and COVID-19 in Latin America and the Caribbean.
    Garcia PJ; Cabrera DM; Cárcamo PM; Diaz MM
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):37-45. PubMed ID: 35092570
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.